News | March 07, 2025
Medicamen Biotech partners with South African business conglomerate
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
In 2023, Endox had revenues of approximately SEK 65 million
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
The company has received the GMP Certification after successful closure of the inspection
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Subscribe To Our Newsletter & Stay Updated
